Proteases in Mycobacterium tuberculosis pathogenesis: potential as drug targets.

TB is still a major global health problem causing over 1 million deaths per year. An increasing problem of drug resistance in the causative agent, Mycobacterium tuberculosis, as well as problems with the current lengthy and complex treatment regimens, lends urgency to the need to develop new antitubercular agents. Proteases have been targeted for therapy in other infections, most notably these have been successful as antiviral agents in the treatment of HIV infection. M. tuberculosis has a number of proteases with good potential as novel drug targets and developing drugs against these should result in agents that are effective against drug-resistant and drug-sensitive strains. In this review, the authors summarize the current status of proteases with potential as drug targets in this pathogen, particularly focusing on proteases involved in protein secretion (signal peptidases LepB and LspA), protein degradation and turnover (ClpP and the proteasome) and virulence (mycosins and HtrA).

[1]  S. Gygi,et al.  Correction: Prokaryotic Ubiquitin-Like Protein (Pup) Proteome of Mycobacterium tuberculosis , 2010, PLoS ONE.

[2]  P. Niyomrattanakit,et al.  The natural product cyclomarin kills Mycobacterium tuberculosis by targeting the ClpC1 subunit of the caseinolytic protease. , 2011, Angewandte Chemie.

[3]  F. Romesberg,et al.  Structural and initial biological analysis of synthetic arylomycin A2. , 2007, Journal of the American Chemical Society.

[4]  David L. Pompliano,et al.  Regulated Expression of the Escherichia coli lepB Gene as a Tool for Cellular Testing of Antimicrobial Compounds That Inhibit Signal Peptidase I In Vitro , 2002, Antimicrobial Agents and Chemotherapy.

[5]  A. Goldberg,et al.  The active ClpP protease from M. tuberculosis is a complex composed of a heptameric ClpP1 and a ClpP2 ring , 2012, The EMBO journal.

[6]  F. Romesberg,et al.  Synthesis and biological evaluation of penem inhibitors of bacterial signal peptidase. , 2009, Bioorganic & medicinal chemistry letters.

[7]  Huilin Li,et al.  Inhibitors Selective for Mycobacterial versus Human Proteasomes , 2009, Nature.

[8]  W. Bishai,et al.  "Depupylation" of prokaryotic ubiquitin-like protein from mycobacterial proteasome substrates. , 2010, Molecular cell.

[9]  F. Romesberg,et al.  Broad-spectrum antibiotic activity of the arylomycin natural products is masked by natural target mutations. , 2010, Chemistry & biology.

[10]  T. Baker,et al.  ATP-dependent proteases of bacteria: recognition logic and operating principles. , 2006, Trends in biochemical sciences.

[11]  C. Nathan,et al.  The Proteasome of Mycobacterium tuberculosis Is Required for Resistance to Nitric Oxide , 2003, Science.

[12]  C. Manoil,et al.  Membrane Proteases and Aminoglycoside Antibiotic Resistance , 2011, Journal of bacteriology.

[13]  Thomas R. Ioerger,et al.  High-Resolution Phenotypic Profiling Defines Genes Essential for Mycobacterial Growth and Cholesterol Catabolism , 2011, PLoS pathogens.

[14]  C. Wilson,et al.  Escherichia coli leader peptidase: production of an active form lacking a requirement for detergent and development of peptide substrates. , 1993, Archives of biochemistry and biophysics.

[15]  C. Crews,et al.  Proteasome inhibition by fellutamide B induces nerve growth factor synthesis. , 2008, Chemistry & biology.

[16]  Tanya Parish,et al.  Gene expression profile of Mycobacterium tuberculosis in a non-replicating state. , 2004, Tuberculosis.

[17]  E. Brown,et al.  C-Terminal Signal Sequence Promotes Virulence Factor Secretion in Mycobacterium tuberculosis , 2006, Science.

[18]  A. Beyer.  Sequence analysis of the AAA protein family , 1997, Protein science : a publication of the Protein Society.

[19]  R. Harvey,et al.  Inhibition of prolipoprotein signal peptidase by globomycin. , 1985, The Journal of biological chemistry.

[20]  H. Song,et al.  Structures of ClpP in complex with acyldepsipeptide antibiotics reveal its activation mechanism , 2010, Nature Structural &Molecular Biology.

[21]  J. Basu,et al.  RseA, the SigE specific anti‐sigma factor of Mycobacterium tuberculosis, is inactivated by phosphorylation‐dependent ClpC1P2 proteolysis , 2010, Molecular microbiology.

[22]  T. Langer,et al.  AAA proteases: cellular machines for degrading membrane proteins. , 2000, Trends in biochemical sciences.

[23]  E. Rubin,et al.  Genes required for mycobacterial growth defined by high density mutagenesis , 2003, Molecular microbiology.

[24]  Chunyan Tang,et al.  Structural insights on the Mycobacterium tuberculosis proteasomal ATPase Mpa. , 2009, Structure.

[25]  H. Sahl,et al.  Antibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell division protein FtsZ , 2011, Proceedings of the National Academy of Sciences.

[26]  R. Siezen,et al.  The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram-positive bacteria , 2001, Genome Biology.

[27]  J. Chien,et al.  HtrA serine proteases as potential therapeutic targets in cancer. , 2009, Current cancer drug targets.

[28]  J. Sello,et al.  Diversity-oriented synthesis of cyclic acyldepsipeptides leads to the discovery of a potent antibacterial agent. , 2010, Bioorganic & medicinal chemistry.

[29]  G. Bruton,et al.  Inhibitors of bacterial signal peptidases. , 1970, Current pharmaceutical design.

[30]  A. Matouschek,et al.  Protein targeting to ATP-dependent proteases. , 2008, Current opinion in structural biology.

[31]  Huilin Li,et al.  Characterization of a Mycobacterium tuberculosis proteasomal ATPase homologue , 2004, Molecular microbiology.

[32]  F. Denizot,et al.  ClpP of Bacillus subtilis is required for competence development, motility, degradative enzyme synthesis, growth at high temperature and sporulation , 1998, Molecular microbiology.

[33]  P. Berche,et al.  The ClpP serine protease is essential for the intracellular parasitism and virulence of Listeria monocytogenes , 2000, Molecular microbiology.

[34]  S. Reed,et al.  Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis. , 1999, Infection and immunity.

[35]  P. Mazodier,et al.  Acyl depsipeptide (ADEP) resistance in Streptomyces. , 2011, Microbiology.

[36]  R. Ghirlando,et al.  Acyldepsipeptide antibiotics induce the formation of a structured axial channel in ClpP: A model for the ClpX/ClpA-bound state of ClpP. , 2010, Chemistry & biology.

[37]  J. Sacchettini,et al.  Structure and function of the virulence-associated high-temperature requirement A of Mycobacterium tuberculosis. , 2008, Biochemistry.

[38]  H. Lilie,et al.  The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease , 2009, EMBO molecular medicine.

[39]  W. Jacobs,et al.  LspA-independent action of globomycin on Mycobacterium tuberculosis. , 2007, The Journal of antimicrobial chemotherapy.

[40]  Nitu Singh,et al.  The structural basis of mode of activation and functional diversity: a case study with HtrA family of serine proteases. , 2011, Archives of biochemistry and biophysics.

[41]  R. Srinivasan,et al.  Functional characterization of AAA family FtsH protease of Mycobacterium tuberculosis. , 2006, FEMS microbiology letters.

[42]  S. Gandotra,et al.  The Mycobacterium tuberculosis Proteasome Active Site Threonine Is Essential for Persistence Yet Dispensable for Replication and Resistance to Nitric Oxide , 2010, PLoS pathogens.

[43]  Tanya Parish,et al.  Validation of the Essential ClpP Protease in Mycobacterium tuberculosis as a Novel Drug Target , 2011, Journal of bacteriology.

[44]  M. Paetzel,et al.  Signal peptidases. , 2002, Chemical reviews.

[45]  S. Butler-Wu,et al.  Identification of substrates of the Mycobacterium tuberculosis proteasome , 2006, The EMBO journal.

[46]  Bryan J. Venters,et al.  Discovery of antibacterial cyclic peptides that inhibit the ClpXP protease , 2007, Protein science : a publication of the Protein Society.

[47]  S. Wodak,et al.  Activators of cylindrical proteases as antimicrobials: identification and development of small molecule activators of ClpP protease. , 2011, Chemistry & biology.

[48]  H. Sahl,et al.  Dysregulation of bacterial proteolytic machinery by a new class of antibiotics , 2005, Nature Medicine.

[49]  W. Hillen,et al.  In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in mice , 2007, Nature Medicine.

[50]  I. Smith,et al.  Global Analysis of the Mycobacterium tuberculosis Zur (FurB) Regulon , 2006, Journal of bacteriology.

[51]  Christian V Forst,et al.  Mycobacterium tuberculosis functional network analysis by global subcellular protein profiling. , 2004, Molecular biology of the cell.

[52]  A. Izzo,et al.  Portrait of a Pathogen: The Mycobacterium tuberculosis Proteome In Vivo , 2010, PloS one.

[53]  A. Cheung,et al.  Proteolytic Regulation of Toxin-Antitoxin Systems by ClpPC in Staphylococcus aureus , 2009, Journal of bacteriology.

[54]  Ashley M. Sherrid,et al.  Characterization of a Clp Protease Gene Regulator and the Reaeration Response in Mycobacterium tuberculosis , 2010, PloS one.

[55]  A. Goldberg,et al.  Mycobacterium tuberculosis ClpP1 and ClpP2 Function Together in Protein Degradation and Are Required for Viability in vitro and During Infection , 2012, PLoS pathogens.

[56]  M. Yarmolinsky,et al.  Addiction protein Phd of plasmid prophage P1 is a substrate of the ClpXP serine protease of Escherichia coli. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[57]  P. Ajitkumar,et al.  Cloning and expression of the gene coding for FtsH protease from Mycobacterium tuberculosis H37Rv. , 1998, Gene.

[58]  Huilin Li,et al.  Structure of the Mycobacterium tuberculosis proteasome and mechanism of inhibition by a peptidyl boronate , 2006, Molecular microbiology.

[59]  V. Mizrahi,et al.  Staphylococcus aureus nuclease is a useful secretion reporter for mycobacteria. , 1999, Gene.

[60]  H. Kogen,et al.  Structure-activity relationships of globomycin analogues as antibiotics. , 2004, Bioorganic & medicinal chemistry.

[61]  S. Ehlers,et al.  Lipoprotein processing is required for virulence of Mycobacterium tuberculosis † , 2004, Molecular microbiology.

[62]  Beatriz de Astorza,et al.  Role of the htrA Gene in Klebsiella pneumoniae Virulence , 2002, Infection and Immunity.

[63]  G. Rummel,et al.  The FtsH protease is involved in development, stress response and heat shock control in Caulobacter crescentus , 2002, Molecular microbiology.

[64]  Petra Schneider,et al.  Inhibitors of Helicobacter pylori Protease HtrA Found by ‘Virtual Ligand’ Screening Combat Bacterial Invasion of Epithelia , 2011, PloS one.

[65]  K. Burns,et al.  Pupylation: proteasomal targeting by a protein modifier in bacteria. , 2012, Methods in molecular biology.

[66]  Michael Hecker,et al.  The ClpP Peptidase Is the Major Determinant of Bulk Protein Turnover in Bacillus subtilis , 2004, Journal of bacteriology.

[67]  M. Page,et al.  Crystallographic and Biophysical Analysis of a Bacterial Signal Peptidase in Complex with a Lipopeptide-based Inhibitor* , 2004, Journal of Biological Chemistry.

[68]  R. Huber,et al.  HTRA proteases: regulated proteolysis in protein quality control , 2011, Nature Reviews Molecular Cell Biology.

[69]  S. Sieber,et al.  Vibralactone as a tool to study the activity and structure of the ClpP1P2 complex from Listeria monocytogenes. , 2011, Angewandte Chemie.

[70]  B. Raynal,et al.  Assembly and proteolytic processing of mycobacterial ClpP1 and ClpP2 , 2011, BMC Biochemistry.

[71]  Wilbert Bitter,et al.  Type VII secretion — mycobacteria show the way , 2007, Nature Reviews Microbiology.

[72]  P. Carroll,et al.  Identifying Vulnerable Pathways in Mycobacterium tuberculosis by Using a Knockdown Approach , 2011, Applied and Environmental Microbiology.

[73]  P. Alzari,et al.  Insights into the inter-ring plasticity of caseinolytic proteases from the X-ray structure of Mycobacterium tuberculosis ClpP1. , 2007, Acta crystallographica. Section D, Biological crystallography.

[74]  N. C. Gey van Pittius,et al.  The mycosins of Mycobacterium tuberculosis H37Rv: a family of subtilisin-like serine proteases. , 2000, Gene.

[75]  C. Craik,et al.  Mycobacterium tuberculosis MycP1 protease plays a dual role in regulation of ESX-1 secretion and virulence. , 2010, Cell host & microbe.

[76]  Vineet Bafna,et al.  Expansion of the mycobacterial "PUPylome". , 2010, Molecular bioSystems.

[77]  S. T. Friedman,et al.  Identification of Genes Encoding Exported Mycobacterium tuberculosis Proteins Using a Tn552′phoA In Vitro Transposition System , 2000, Journal of bacteriology.

[78]  M. Paetzel,et al.  The structure and mechanism of bacterial type I signal peptidases. A novel antibiotic target. , 2000, Pharmacology & therapeutics.

[79]  H. Ingmer,et al.  Clp ATPases and ClpP proteolytic complexes regulate vital biological processes in low GC, Gram‐positive bacteria , 2007, Molecular microbiology.

[80]  H. Engelberg-Kulka,et al.  An Escherichia coli chromosomal "addiction module" regulated by guanosine [corrected] 3',5'-bispyrophosphate: a model for programmed bacterial cell death. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Huilin Li,et al.  Fellutamide B is a potent inhibitor of the Mycobacterium tuberculosis proteasome. , 2010, Archives of biochemistry and biophysics.

[82]  I. Smith,et al.  Mechanisms of iron regulation in mycobacteria: role in physiology and virulence , 2003, Molecular microbiology.

[83]  T. Parish,et al.  Inhibition of the Sole Type I Signal Peptidase of Mycobacterium tuberculosis Is Bactericidal under Replicating and Nonreplicating Conditions , 2012, Journal of bacteriology.

[84]  J. Betts,et al.  Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling , 2002, Molecular microbiology.

[85]  Beat Amstutz,et al.  Deletion of dop in Mycobacterium smegmatis abolishes pupylation of protein substrates in vivo , 2010, Molecular microbiology.

[86]  A. Allsop,et al.  On the catalytic mechanism of prokaryotic leader peptidase 1. , 1992, The Biochemical journal.

[87]  R. Pukall,et al.  Arylomycins A and B, new biaryl-bridged lipopeptide antibiotics produced by Streptomyces sp. Tü 6075. I. Taxonomy, fermentation, isolation and biological activities. , 2002, The Journal of antibiotics.